Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype.
about
Masquerading microbial pathogens: capsular polysaccharides mimic host-tissue moleculesBioluminescent imaging reveals novel patterns of colonization and invasion in systemic Escherichia coli K1 experimental infection in the neonatal rat.Bacteriophages and phage-derived proteins--application approachesAn Overview of Two-Component Signal Transduction Systems Implicated in Extra-Intestinal Pathogenic E. coli InfectionsPostnatal development of the small intestinal mucosa drives age-dependent, regio-selective susceptibility to Escherichia coli K1 infection.Two T7-like Bacteriophages, K5-2 and K5-4, Each Encodes Two Capsule Depolymerases: Isolation and Functional CharacterizationAdministration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1Depolymerase improves gentamicin efficacy during Klebsiella pneumoniae induced murine infection.Multifarious roles of sialic acids in immunity.Altered innate defenses in the neonatal gastrointestinal tract in response to colonization by neuropathogenic Escherichia coli.Isolation of a bacteriophage specific for a new capsular type of Klebsiella pneumoniae and characterization of its polysaccharide depolymerase.Identification of capsular types in carbapenem-resistant Klebsiella pneumoniae strains by wzc sequencing and implications for capsule depolymerase treatmentPhenotypic resistance and the dynamics of bacterial escape from phage control.Non-invasive model of neuropathogenic Escherichia coli infection in the neonatal rat.Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracisAeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin.Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.Host-like carbohydrates promote bloodstream survival of Vibrio vulnificus in vivo.The Genotoxin Colibactin Is a Determinant of Virulence in Escherichia coli K1 Experimental Neonatal Systemic InfectionPathoadaptive Mutations of Escherichia coli K1 in Experimental Neonatal Systemic Infection.Towards rational treatment of bacterial infections during extended space travelParenteral Administration of Capsule Depolymerase EnvD Prevents Lethal Inhalation Anthrax InfectionTreatment of experimental anthrax with recombinant capsule depolymerasePoly-γ-(D)-glutamic acid capsule interferes with lytic infection of Bacillus anthracis by B. anthracis-specific bacteriophagesDifferential expression of the polysialyl capsule during blood-to-brain transit of neuropathogenic Escherichia coli K1.Polysialic acid, a glycan with highly restricted expression, is found on human and murine leukocytes and modulates immune responses.Capsule-Targeting Depolymerase, Derived from Klebsiella KP36 Phage, as a Tool for the Development of Anti-Virulent Strategy.Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection processNeonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state.Host Sialic Acids: A Delicacy for the Pathogen with Discerning Taste.Bacteriophage-encoded depolymerases: their diversity and biotechnological applications.The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages.Draft Genome Sequences of Pseudomonas fluorescens BS2 and Pusillimonas noertemannii BS8, Soil Bacteria That Cooperate To Degrade the Poly-γ-d-Glutamic Acid Anthrax Capsule.A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.Identification and Characterization of Dpo42, a Novel Depolymerase Derived from the Escherichia coli Phage vB_EcoM_ECOO78.Identification of amino acid residues at the active site of endosialidase that dissociate the polysialic acid binding and cleaving activities in Escherichia coli K1 bacteriophages.In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model.The Bacterial Stress-Responsive Hsp90 Chaperone (HtpG) Is Required for the Production of the Genotoxin Colibactin and the Siderophore Yersiniabactin in Escherichia coli.The effects of upaB deletion and the double/triple deletion of upaB, aatA, and aatB genes on pathogenicity of avian pathogenic Escherichia coli.Synergy as a rationale for phage therapy using phage cocktails.
P2860
Q26865784-33BE15DD-32A1-4EA3-9850-7E544A2F8363Q27322628-5AB7E53B-864B-49F8-AD9D-D459690806D8Q28082731-A8D00F76-6CCB-49F2-B5DF-862104B3790DQ33650044-D98247FA-94E9-4069-8D6F-D3A6523CADA2Q33669559-0030EC5C-3177-4A2C-B061-2F50CEC10F5EQ33870684-5D4BDF9A-2F12-4159-99F6-4CD92684BA68Q34071207-6A200E6F-096D-4A36-934E-B2F41B9421FBQ34116324-B1A7081B-30E0-4B8C-AC84-897E8CD27C95Q34270155-F265B541-A3D3-4063-809C-423D1A8327BCQ34782538-B8FDA3FF-834A-487B-8C5E-4EAF548EB0DDQ34925036-FC5BE3AA-931D-4257-8E4C-296F1EF542A7Q35105895-4010A93C-0F57-49C3-B9B0-761BF349E93FQ35151582-554AFF19-2607-496D-87DD-B7C2C04CB44CQ35158433-40A6646E-B35D-4F09-9046-BFD400882014Q35635634-904077F4-9FA9-4314-B8D0-3EF7CFFA02BDQ35660517-FAAF9223-3D8C-45DF-83A0-2551D5256B41Q35778177-9AADF885-0499-4264-B462-BA5C8040E816Q35833811-D552D35A-A2A5-4F35-A46A-7C2C51859A65Q35947396-918C5084-745A-4013-A7C6-F466C0AEB24AQ36197313-E8419FDA-F3B6-469F-870D-236DCF560FE9Q36238836-1E9B77AA-5B32-4BEE-8035-3B66D9698F8AQ36290799-7C439006-002D-4840-9E8F-978E4D216C31Q36482838-FCEC0979-5043-438C-BF00-6CBE430FE940Q36558644-E81F7A6A-ED05-4E90-B546-8165EE2061B0Q36946748-BD3AD73D-1F5C-400D-B246-E7FC368DC87CQ37283504-8AB86F6D-ECA9-4254-B856-78CD77AADADEQ37539282-DF274499-F550-4194-ABA8-02B421555579Q37737552-59294476-69C8-49AF-A3A2-E82913E35373Q38161438-CB20690B-1E41-41B9-ACC1-7E463232117CQ38583064-46CDC964-B58F-4EC1-9E8E-DE82858AB94AQ38696760-286425F8-6BE4-424C-BAD4-DE3E06AA0AD5Q39083103-B04464B3-CD93-4533-BD42-412DEE424832Q39485470-B71C2A05-269B-48B6-8BAF-82FB4D532F49Q39747962-CDA8708C-95F2-47F6-8458-90CB4E1F5477Q40086431-54029E50-1961-4821-9C70-8621F3B73E3DQ40152429-7D478B42-D724-456A-8987-59A44FCD1FC8Q40601668-6E4774B8-EC75-4B6E-B377-9728F834497FQ40614480-A508FB9D-09A6-47B0-981C-DEAF2BB4B421Q41049621-35868E2F-0ACA-41AB-8005-41724660497FQ41717404-DDD9D5DC-6106-4ACD-AAC7-587B54B51BC5
P2860
Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Prevention and cure of systemi ...... on of the bacterial phenotype.
@en
type
label
Prevention and cure of systemi ...... on of the bacterial phenotype.
@en
prefLabel
Prevention and cure of systemi ...... on of the bacterial phenotype.
@en
P2093
P2860
P1476
Prevention and cure of systemi ...... on of the bacterial phenotype.
@en
P2093
J Paul Luzio
Maria B Redpath
Naseem Mushtaq
Peter W Taylor
P2860
P304
P356
10.1128/AAC.48.5.1503-1508.2004
P407
P577
2004-05-01T00:00:00Z